These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14057909)

  • 21. Synthesis of novel N-substituted imidazolecarboxylic acid hydrazides as monoamine oxidase inhibitors.
    Hadizadeh F; Ghodsi R
    Farmaco; 2005 Mar; 60(3):237-40. PubMed ID: 15784243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and monoamine oxidase inhibitory activity of some pentafluorobenzylidenes and their corresponding hydrazines.
    Aboul-Enein HY; El-Obeid HA; El-Farra AA
    Pharm Acta Helv; 1980; 55(10):282-4. PubMed ID: 7454735
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE EFFECT OF CERTAIN MONOAMINE OXIDASE ON THE CORONARY BLOOD FLOW. I. THE EFFECT ON THE CORONARY VESSELS OF THE ISOLATED HEART].
    BANASZKIEWICZ W; CHODERA A
    Acta Physiol Pol; 1965; 16():315-9. PubMed ID: 14340008
    [No Abstract]   [Full Text] [Related]  

  • 24. MONOAMINE OXIDASE INHIBITORS. III. STRUCTURAL VARIATIONS IN 1-ALKYL AND 1-ARALKYL-1(OR 2)-ACYLHYDRAZINES.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1962 May; 5():503-13. PubMed ID: 14056387
    [No Abstract]   [Full Text] [Related]  

  • 25. ACTION OF N-O-CHLOROBENZYL-N'N"-DIMETHYLGUANIDINE (BW392C60), A BRETYLIUM-LIKE DRUG IN LOWERING THE INTRAOCULAR PRESSURE OF RABBIT EYES.
    GESSA GL; SANGIORGI G
    J Pharm Pharmacol; 1964 Sep; 16():630-1. PubMed ID: 14234874
    [No Abstract]   [Full Text] [Related]  

  • 26. [PHARMACOLOGY OF SOME NEW HYPOTENSIVE DRUGS].
    KRUSHKOV I
    Suvr Med (Sofiia); 1964; 15():46-54. PubMed ID: 14247058
    [No Abstract]   [Full Text] [Related]  

  • 27. THE EFFECTS OF SOME ARALKYLGUANIDINES IN MICE.
    FIELDEN R; GREEN AL
    Br J Pharmacol Chemother; 1965 Apr; 24(2):408-17. PubMed ID: 14325336
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence for rapid turnover of norepinephrine in rat heart and brain.
    SPECTOR S; MELMON K; SJOERDSMA A
    Proc Soc Exp Biol Med; 1962 Oct; 111():79-81. PubMed ID: 13989972
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the storage of norepinephrine and the effect of drugs.
    POTTER LT; AXELROD J
    J Pharmacol Exp Ther; 1963 May; 140():199-206. PubMed ID: 13985751
    [No Abstract]   [Full Text] [Related]  

  • 30. SYNTHESIS AND BIOLOGICAL PROPERTIES OF AMINOALKYLHYDRAZINES. A UNIQUE NITROGEN-NITROGEN SCISSION OF 1-(2-DIETHYLAMINOETHYL)-2-(1-PHENYL-2-PROPYL)H0YDRAZINE.
    ELSLAGER EF; WEINSTEIN EA; WORTH DF
    J Med Chem; 1964 Jul; 7():493-500. PubMed ID: 14221133
    [No Abstract]   [Full Text] [Related]  

  • 31. [Potential psychotropic drugs. V. Monoamine oxidase inhibitors. Preparation and study of some indolyl-3 alkyl-hydrazines].
    Bernabé M; Fernández-Alvarez E; Lora-Tamayo M; Nieto O
    Bull Soc Chim Fr; 1971 May; 5():1882-7. PubMed ID: 5559069
    [No Abstract]   [Full Text] [Related]  

  • 32. [Potential psychotropes. 7. Monoamine oxidase inhibitors. Preparation and study of N' substituted 2-(alcoxy-6 indolyl) carbohydrazides].
    Pastor IC; Alvarez EF; Lora-Tamayo M
    Bull Soc Chim Fr; 1972 Dec; 12():4722-31. PubMed ID: 4653550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Neurotropic and psychotropic compounds. 36. Some cycloalkylhydrazines and aralkylhydrazines].
    Seidlová V; Vejdĕlek ZJ; Raisner M; Jirkovský I; Protiva M
    Cesk Farm; 1969 Jun; 18(4):190-7. PubMed ID: 5805336
    [No Abstract]   [Full Text] [Related]  

  • 34. [Potential psychotropic agents. I. Synthesis of 1-(2-indolylcarbonyl)-2-alkylhydrazines, 1-(3-indolylcarbonyl)-2-alkylhydrazines and 1-(3-indolylacetyl)-2-alkylhydrazines, and measurement, in vitro, of their monoamine oxidase inhibitory activity].
    Alemany A; Bernabé M; Elorriaga C; Fernández Alvarez E; Lora-Tamayo M; Nieto O
    Bull Soc Chim Fr; 1966 Aug; 8():2486-97. PubMed ID: 5974696
    [No Abstract]   [Full Text] [Related]  

  • 35. Some structural considerations regarding compounds that influence monoamine metabolism.
    BLOOM BM
    Ann N Y Acad Sci; 1963 Jul; 107():878-90. PubMed ID: 13971780
    [No Abstract]   [Full Text] [Related]  

  • 36. [EFFECTS OF 6 DRUGS ON THE PRODUCTION OF RENAL HYPERTENSION IN RATS].
    LIU JF; LI HY; TING KS
    Yao Xue Xue Bao; 1962 Nov; 9():657-60. PubMed ID: 14075920
    [No Abstract]   [Full Text] [Related]  

  • 37. [Synthesis of Tersavid].
    Mukhina NA; Gilev AP; Klimenko VG
    Med Prom SSSR; 1965 Jul; 19(7):9-11. PubMed ID: 5868764
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacological studies of a medicinal agent used in anesthesiology].
    de CAMPOS JS
    Rev Bras Cir; 1963 Feb; 45():74-85. PubMed ID: 14018190
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of bretyllium and guanethidine in hypertension.
    Roy SB; Gupta MP; Mathur VS; Bhatia ML
    J Indian Med Assoc; 1967 Jan; 48(2):64-9. PubMed ID: 6038524
    [No Abstract]   [Full Text] [Related]  

  • 40. [The sodium nitrosoferricyanide reagent. Application to the identification of antitubercular agents, monoamine oxidase inhibitors and antibiotics].
    ROUX A; ROUX-MATIGNON J
    Ann Pharm Fr; 1963 Mar; 21():255-60. PubMed ID: 13982749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.